967 research outputs found
New Bedford Working Capital Network progress panel
Since 1993 a growing number of New Bedford Area micro-entrepeneurs have gained access to credit, training and networking through participation in the New Bedford Working Capital Network sponsored by PACE, a community action agency. To ensure the network continues its expansion while maintaining and improving the quality of service provided, a strategy was developed to achieve sustainability within the next three to five years. At the core of this strategy is the Progress Panel, a participant led governing structure which will have responsibility over most aspects of the program operations. This thesis examines the evolution of a working capital model as part of a micro-enterprise development program with an eye toward replication of the model. (Library-derived description)Maddocks, W. O. (1996). New Bedford Working Capital Network progress panel. Retrieved from http://academicarchive.snhu.eduMaster of Science (M.S.)School of Community Economic Developmen
Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: a prospective cohort study.
BACKGROUND AND OBJECTIVE: Gait speed is associated with survival in individuals with idiopathic pulmonary fibrosis (IPF). The extent to which four-metre gait speed (4MGS) decline predicts adverse outcome in IPF remains unclear. We aimed to examine longitudinal 4MGS change and identify a cut-point associated with adverse outcome. METHODS: In a prospective cohort study, we recruited 132 individuals newly diagnosed with IPF and measured 4MGS change over 6 months. Death/first hospitalization at 6 months were composite outcome events. Complete data (paired 4MGS plus index event) were available in 85 participants; missing 4MGS data were addressed using multiple imputation. Receiver-Operating Curve plots identified a 4MGS change cut-point. Cox proportional-hazard regression assessed the relationship between 4MGS change and time to event. RESULTS: 4MGS declined over 6 months (mean [95% CI] change: -0.05 [-0.09 to -0.01] m/s; p = 0.02). A decline of 0.07 m/s or more in 4MGS over 6 months had better discrimination for the index event than change in 6-minute walk distance, forced vital capacity, Composite Physiologic Index or Gender Age Physiology index. Kaplan-Meier curves demonstrated a significant difference in time to event between 4MGS groups (substantial decline: >-0.07 m/s versus minor decline/improvers: ≤-0.07 m/s; p = 0.007). Those with substantial decline had an increased risk of hospitalization/death (adjusted hazard ratio [95% CI] 4.61 [1.23-15.83]). Similar results were observed in multiple imputation analysis. CONCLUSION: In newly diagnosed IPF, a substantial 4MGS decline over 6 months is associated with shorter time to hospitalization/death at 6 months. 4MGS change has potential as a surrogate endpoint for interventions aimed at modifying hospitalization/death
Stereotyping starlings are more 'pessimistic'.
Negative affect in humans and animals is known to cause individuals to interpret ambiguous stimuli pessimistically, a phenomenon termed 'cognitive bias'. Here, we used captive European starlings (Sturnus vulgaris) to test the hypothesis that a reduction in environmental conditions, from enriched to non-enriched cages, would engender negative affect, and hence 'pessimistic' biases. We also explored whether individual differences in stereotypic behaviour (repetitive somersaulting) predicted 'pessimism'. Eight birds were trained on a novel conditional discrimination task with differential rewards, in which background shade (light or dark) determined which of two covered dishes contained a food reward. The reward was small when the background was light, but large when the background was dark. We then presented background shades intermediate between those trained to assess the birds' bias to choose the dish associated with the smaller food reward (a 'pessimistic' judgement) when the discriminative stimulus was ambiguous. Contrary to predictions, changes in the level of cage enrichment had no effect on 'pessimism'. However, changes in the latency to choose and probability of expressing a choice suggested that birds learnt rapidly that trials with ambiguous stimuli were unreinforced. Individual differences in performance of stereotypies did predict 'pessimism'. Specifically, birds that somersaulted were more likely to choose the dish associated with the smaller food reward in the presence of the most ambiguous discriminative stimulus. We propose that somersaulting is part of a wider suite of behavioural traits indicative of a stress response to captive conditions that is symptomatic of a negative affective state
Experiences of staff providing specialist palliative care during COVID-19: a multiple qualitative case study
Objective: To explore the experiences of, and impact on, staff working in palliative care during the COVID-19 pandemic. Design: Qualitative multiple case study using semi-structured interviews between November 2020 and April 2021 as part of the CovPall study. Data were analysed using thematic framework analysis. Setting: Organisations providing specialist palliative services in any setting. Participants: Staff working in specialist palliative care, purposefully sampled by the criteria of role, care setting and COVID-19 experience. Main outcome measures: Experiences of working in palliative care during the COVID-19 pandemic. Results: Five cases and 24 participants were recruited (n = 12 nurses, 4 clinical managers, 4 doctors, 2 senior managers, 1 healthcare assistant, 1 allied healthcare professional). Central themes demonstrate how infection control constraints prohibited and diluted participants’ ability to provide care that reflected their core values, resulting in experiences of moral distress. Despite organisational, team and individual support strategies, continually managing these constraints led to a ‘crescendo effect’ in which the impacts of moral distress accumulated over time, sometimes leading to burnout. Solidarity with colleagues and making a valued contribution provided ‘moral comfort’ for some. Conclusions: This study provides a unique insight into why and how healthcare staff have experienced moral distress during the pandemic, and how organisations have responded. Despite their experience of dealing with death and dying, the mental health and well-being of palliative care staff was affected by the pandemic. Organisational, structural and policy changes are urgently required to mitigate and manage these impacts
A longitudinal study of muscle strength and function in patients with cancer cachexia
Purpose
Patients with cancer frequently experience an involuntary loss of weight (in particular loss of muscle mass), defined as cachexia, with profound implications for independence and quality of life. The rate at which such patients’ physical performance declines has not been well established. The aim of this study was to determine the change in muscle strength and function over 8 weeks in patients with already established cancer cachexia, to help inform the design and duration of physical activity interventions applicable to this patient group.
Methods
Patients with thoracic and gastrointestinal cancer, with unintentional weight loss of >5% in 6 months or BMI < 20 plus 2% weight loss were included. Physical and functional assessments (baseline, 4 weeks, 8 weeks) included: isometric quadriceps and hamstring strength, handgrip, standing balance, 10m walk time and timed up and go.
Results
Fifty patients (32 male), mean ±SD age 65 ±10 years and BMI 24.9 ±4.3kg/m2 were recruited. Thoracic cancer patients had lower muscle strength and function (p0.05). Baseline variables did not differentiate between completers and non-completers (p>0.05).
Conclusions
More than a third of patients with established cancer cachexia in our study were stable over 8 weeks, suggesting a subgroup who may benefit from targeted interventions of reasonable duration. Better understanding the physical performance parameters which characterize and differentiate these patients has important clinical implications for cancer multidisciplinary team practice
Minimal versus specialist equipment in the delivery of pulmonary rehabilitation: Protocol for a non-inferiority randomised controlled trial
Introduction Pulmonary rehabilitation (PR), an exercise
and education programme for people with chronic lung
disease, aims to improve exercise capacity, breathlessness
and quality of life. Most evidence to support PR is from
trials that use specialist exercise equipment, for example,
treadmills (PR-gym). However, a significant proportion of
programmes do not have access to specialist equipment
with training completed with minimal exercise equipment
(PR-min). There is a paucity of robust literature examining
the efficacy of supervised, centre-based PR-min. We aim
to determine whether an 8-week supervised, centre-based
PR-min programme is non-inferior to a standard 8-week
supervised, centre-based PR-gym programme in terms of
exercise capacity and health outcomes for patients with
chronic lung disease.
Methods and analysis Parallel, two-group, assessor blinded and statistician-blinded, non-inferiority randomised
trial. 436 participants will be randomised using
minimisation at the individual level with a 1:1 allocation to
PR-min (intervention) or PR-gym (control). Assessment will
take place pre-PR (visit 1), post-PR (visit 2) and 12 months
following visit 1 (visit 3). Exercise capacity (incremental
shuttle walk test), dyspnoea (Chronic Respiratory
Questionnaire (CRQ)-Dyspnoea), health-related quality
of life (CRQ), frailty (Short Physical Performance Battery),
muscle strength (isometric quadriceps maximum voluntary
contraction), patient satisfaction (Global Rating of Change
Questionnaire), health economic as well as safety and
trial process data will be measured. The primary outcome
is change in exercise capacity between visit 1 and visit
2. Two sample t-tests on an intention to treat basis will
be used to estimate the difference in mean primary and
secondary outcomes between patients randomised to PR gym and PR-min.
Ethics and dissemination London-Camden and Kings
Cross Research Ethics Committee and Health Research
Authority have approved the study (18/LO/0315). Results
will be submitted for publication in peer-reviewed journals,
presented at international conferences, disseminated
through social media, patient and public routes and
directly shared with stakeholders.
Trial registration number ISRCTN16196765.National Institute for Health Research grant number PB-PG-0816–2002
Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery
Copyright © 2023 The Author(s). Background: Identifying frailty in people with chronic obstructive pulmonary disease (COPD) is deemed important, yet comparative characteristics of the most commonly used frailty measures in COPD are unknown. This study aimed to compare how the Fried Frailty Phenotype (FFP) and Short Physical Performance Battery (SPPB) characterise frailty in people with stable COPD, including prevalence of and overlap in identification of frailty, disease and health characteristics of those identified as living with frailty, and predictive value in relation to survival time.
Methods: Cohort study of people with stable COPD attending outpatient clinics. Agreement between frailty classifications was described using Cohen’s Kappa. Disease and health characteristics of frail versus not frail participants were compared using t-, Mann–Whitney U and Chi-Square tests. Predictive value for mortality was examined with multivariable Cox regression.
Results: Of 714 participants, 421 (59%) were male, mean age 69.9 years (SD 9.7), mean survival time 2270 days (95% CI 2185– 2355). Similar proportions were identified as frail using the FFP (26.2%) and SPPB (23.7%) measures; classifications as frail or not frail matched in 572 (80.1%) cases, showing moderate agreement (Kappa = 0.469, SE = 0.038, p < 0.001). Discrepancies seemed driven by FFP exhaustion and weight loss criteria and the SPPB balance component. People with frailty by either measure had worse exercise capacity, health-related quality of life, breathlessness, depression and dependence in activities of daily living. In multivariable analysis controlling for the Age Dyspnoea Obstruction index, sex, BMI, comorbidities and exercise capacity, both the FFP and SPPB had predictive value in relation to mortality (FFP aHR = 1.31 [95% CI 1.03– 1.66]; SPPB aHR = 1.29 [95% CI 0.99– 1.68]).
Conclusion: In stable COPD, both the FFP and SPPB identify similar proportions of people living with/without frailty, the majority with matching classifications. Both measures can identify individuals with multidimensional health challenges and increased mortality risk and provide additional information alongside established prognostic variables.Medical Research Council New Investigator Research Grant and a National Institute for Health and Care Research (NIHR) Clinician Scientist Award (DHCS/07/07/009) held by WDCM and a NIHR Career Development Fellowship (CDF-2017-10-009) held by MM. RB is funded an NIHR Clinical Doctoral Research Fellowship (ICA-CDRF-2017-03-018). CE is funded by a Health Education England/National Institute of Health Research Senior Clinical Lectureship (ICA-SCL-2015-01-001)
Integrating home-based exercise training with a hospital at home service for patients hospitalised with acute exacerbations of COPD: Developing the model using accelerated experience-based Co-design
Background: Hospital at home (HaH) schemes allow early discharge of patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Traditional outpatient pulmonary rehabilitation (PR) following an AECOPD has an established evidence-base, but there are issues with low referral, uptake and completion. One commonly cited barrier to PR post-hospitalisation relates to poor accessibility. To address this, the aim of this project was to enrol service users (patients with COPD and informal carers) and healthcare professionals to co-design a model of care that integrates home-based exercise training within a HaH scheme for patients discharged from hospital following AECOPD.
Methods: This accelerated experience-based co-design project included three audio-recorded stakeholder feedback events, using key “touchpoints” from previous qualitative interviews and a recent systematic review. Audio-recordings were inductively analysed using directed content analysis. An integrated model of care was then developed and finalised through two co-design groups, with the decision-making process facilitated by the tables of changes approach.
Results: Seven patients with COPD, two informal carers and nine healthcare professionals (from an existing outpatient PR service and HaH scheme) participated in the stakeholder feedback events. Four key themes were identified: 1) individualisation, 2) progression and transition, 3) continuity between services, and 4) communication between stakeholders. Two patients with COPD, one informal carer and three healthcare professionals participated in the first joint co-design group, with five healthcare professionals attending a second co-design group. These achieved a consensus on the integrated model of care. The agreed model comprised face-to-face supervised, individually tailored home-based exercise training one to three times a week, delivered during HaH scheme visits where possible by a healthcare professional competent to provide both home-based exercise training and usual HaH care.
Conclusion: An integrated model of care has been co-designed by patients with COPD, informal carers and healthcare professionals to address low uptake and completion of PR following AECOPD. The co-designed model of care has now been integrated within a well-established HaH scheme
Muscle stimulation in advanced idiopathic pulmonary fibrosis: A randomised placebo-controlled feasibility study
Objectives To assess the acceptability of
neuromuscular electrical stimulation (NMES) of the
quadriceps muscles in people with idiopathic pulmonary
fibrosis (IPF) and to identify whether a future definitive
trial is feasible.
Design A randomised, parallel, two-group, participant and
assessor-blinded, placebo-controlled feasibility trial with
embedded qualitative interviews.
Setting Outpatient department, Royal Brompton and
Harefield Hospitals.
Participants Twenty-two people with IPF: median (25th,
75th centiles) age 76 (74, 82) years, forced vital capacity
62 (50, 75) % predicted, 6min walk test distance 289
(149, 360) m.
Interventions Usual care (home-based exercise, weekly
telephone support, breathlessness management leaflet)
with either placebo or active NMES for 6weeks, with
follow-up at 6 and 12 weeks.
Primary outcome measures Feasibility of recruitment
and retention, treatment uptake and adherence, outcome
assessments, participant and outcome assessor blinding
and adverse events related to interventions.
Secondary outcome measures Outcome measures
with potential to be primary or secondary outcomes in a
definitive clinical trial. In addition, purposively sampled
participants were interviewed to capture their experiences
and acceptability of the trial.
Results Out of 364 people screened, 23 were recruited:
11 were allocated to each group and one was withdrawn
prior to randomisation. Compared with the control
group, a greater proportion of the intervention group
completed the intervention, remained in the trial blinded
to group allocation and experienced intervention-related
adverse events. Assessor blinding was maintained. The
secondary outcome measures were feasible with most
missing data associated with the accelerometer. Small
participant numbers precluded identification of an outcome
measure suitable for a definitive trial. Qualitative findings
demonstrated that trial process and active NMES were
acceptable but there were concerns about the credibility of
placebo NMES. Conclusions Primarily owing to recruitment difficulties, a
definitive trial using the current protocol to evaluate NMES
in people with IPF is not feasible.
Trial registration number NCT03499275.British Lung Foundation IPF Project Grant (grant number IPF/PG/17-15
Recommended from our members
COPD discharge bundle and pulmonary rehabilitation referral and uptake following hospitalisation for acute exacerbation of COPD
Supplementary Data: This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content: Data supplement 1 available at: https://thorax.bmj.com/highwire/filestream/198799/field_highwire_adjunct_files/0/thoraxjnl-2020-215464supp001_data_supplement.pdfCopyright © Author(s) (or their employer(s)) 2021. Pulmonary rehabilitation (PR) following hospitalisations for acute exacerbation of COPD (AECOPD) is associated with improved exercise capacity and quality of life, and reduced readmissions. However, referral for, and uptake of, post-hospitalisation PR are low. In this prospective cohort study of 291 consecutive hospitalisations for AECOPD, COPD discharge bundles delivered by PR practitioners compared with non-PR practitioners were associated with increased PR referral (60% vs 12%, p<0.001; adjusted OR: 14.46, 95% CI: 5.28 to 39.57) and uptake (40% vs 32%, p=0.001; adjusted OR: 8.60, 95% CI: 2.51 to 29.50). Closer integration between hospital and PR services may increase post-hospitalisation PR referral and uptake.National Institute for Health Research (NIHR) under its Clinical Doctoral Fellowship Programme (Fellowship Reference Number ICA-CDRF-2017-03-018); NIHR Doctoral Research Fellowship (DRF-2014-07-089) and a NIHR Clinical Trials Fellowship (CTF-2017-06-005); NIHR Career Development Fellowship (CDF-2017-10-009) and NIHR Applied Research Collaboration South London; NIHR Applied Research Collaboration East of England programme
- …